“【 YEOTOP4 】 쩜 【 COM 】신방화오피❍신방화마사지❙신방화건마♀신방화휴게텔ⅲ신방화오피び신방화안마じ신방화립카페”的搜索结果，显示 291-300 项，共有 9444 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate olaparib and temozolomide in treating patients with uterine leiomyosarcoma (LMS) that has spread to other places of ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Establish a prospective database of all patients with peritoneal surface malignancies seen by Dr. Travis Grotz at the Mayo Clinic, Rochester. Design and ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Cohort 1 includes blood collections for in vitro studies which are a component of NIH-funded Project 3 within the Mayo Clinic Pancreatic SPORE, “Optimal ...

4. 神经科- 临床试验- 妙佑医疗国际

   Rochester, Minn., Scottsdale/Phoenix, Ariz. The purpose of this study is to see if Magnetic Resonance Elastography (MRE) a recently developed imaging technique ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the optimal biologic dose (OBD) and recommended Phase 2 dose (RP2D) of BMF-219 monotherapy (Cohorts 1, 2, 3, and 4).

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of ths study is to find out more about the side effects of two new drug combinations for lymphoma, TTI-621 and pembrolizumab and ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the optimal biologic dose (OBD) and recommended Phase 2 dose (RP2D) of BMF-219 monotherapy (Cohorts 1, 2, 3, and 4).

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the optimal biologic dose (OBD) and recommended Phase 2 dose (RP2D) of BMF-219 monotherapy (Cohorts 1, 2, 3, and 4).

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    A Study to Evaluate Immune-related Biomarkers for Pathological Response in Stage II-III HER2-positive Breast Cancer. Rochester, Minn., Jacksonville, Fla ...